Volume 116, Issue 6 pp. 491-498

Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue

SARA JONMARKER

SARA JONMARKER

Dept of Oncology-Pathology, Karolinska Institutet, Stockholm

Search for more papers by this author
AXEL GLAESSGEN

AXEL GLAESSGEN

Dept of Oncology-Pathology, Karolinska Institutet, Stockholm

Search for more papers by this author
W. DAVID CULP

W. DAVID CULP

Dept of Oncology-Pathology, Karolinska Institutet, Stockholm

National Institutes of Health, Bethesda, USA

Search for more papers by this author
PAVEL PISA

PAVEL PISA

Dept of Oncology-Pathology, Karolinska Institutet, Stockholm

Search for more papers by this author
ROLF LEWENSOHN

ROLF LEWENSOHN

Dept of Oncology-Pathology, Karolinska Institutet, Stockholm

Search for more papers by this author
PETER EKMAN

PETER EKMAN

Dept of Urology, Karolinska University Hospital, Stockholm, Sweden

Search for more papers by this author
ALEXANDER VALDMAN

ALEXANDER VALDMAN

Dept of Oncology-Pathology, Karolinska Institutet, Stockholm

Search for more papers by this author
LARS EGEVAD

Corresponding Author

LARS EGEVAD

International Agency for Research on Cancer, Lyon, France

Lars Egevad, International Agency for Research on Cancer (IARC), World Health Organization (WHO), 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France. e-mail: [email protected]Search for more papers by this author
First published: 13 August 2008
Citations: 20

Received 11 December 2007.

Accepted 10 January 2008.

Abstract

Pancreatic duodenal homeobox 1 (PDX-1), a Hox type transcription factor, is necessary for differentiation of exocrine and endocrine pancreas, and regulates insulin gene transcription. PDX-1 expression was studied by immunohistochemistry on a tissue microarray (TMA) of 289 primary prostate cancers (PCa) from radical prostatectomy (RP) specimens with median follow-up of 48.9 months. We separately arrayed benign prostatic tissue, atrophy, high-grade prostatic intraepithelial neoplasia (HGPIN) and PCa from 40 men and also 17 lymph node metastases. Intensity and extent of immunoreactivity and their product (IRp) were evaluated by two independent observers. PDX-1 was overexpressed in cancer vs benign tissue (p<0.001), but also in atrophy and HGPIN vs cancer (p<0.001 and p=0.022, respectively). PDX-1 expression did not correlate with biochemical recurrence, but decreased with higher Gleason pattern (p<0.001) and in metastases vs primary PCa (p<0.001). Weighted kappa for interobserver agreement of intensity, extent and IRp was 0.65, 0.13 and 0.54, respectively. Presence of PDX-1 protein in benign and malignant prostatic tissue was confirmed by Western blot. In view of recent attention to the role of insulin systems in men with PCa, this protein is of interest in the pathogenesis of PCa.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.